Literature DB >> 7819065

A variant of spectrin low-expression allele alpha LELY carrying a hereditary elliptocytosis mutation in codon 28.

J Randon1, L Boulanger, J Marechal, M Garbarz, A Vallier, L Ribeiro, G Tamagnini, D Dhermy, J Delaunay.   

Abstract

Allele alpha LELY is a low-expression allele of the erythroid spectrin alpha-gene. It carries mutations in exon 40 (alpha V/41 polymorphism) and intron 45, respectively, and is associated with partial skipping of exon 46. The latter phenomenon is thought to impair the recruitment of alpha-chains by beta-chains, and would eventually account for the low-expression character. When it occurs in trans to an alpha-allele responsible for hereditary elliptocytosis (alpha HE allele; alpha HE/alpha LELY diplotype), allele alpha LELY enhances the severity of elliptocytosis. Because allele alpha LELY is widespread, we anticipated that it would occasionally carry HE determinants. These variants of allele alpha LELY will be designated alpha HE-LELY allele. The HE component was the known alpha 28 Arg-->His mutation. This alpha HE-LELY allele was investigated within the alpha HE-LELY/alpha LELY diplotype, a diplotype not described before. Except for the neonatal period, the presentation was mild. In a consistent manner, the alpha LELY component in cis of the alpha HE mutation counteracted the like component in trans.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7819065     DOI: 10.1111/j.1365-2141.1994.tb05070.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  7 in total

1.  Evidence that the penetrance of mutations at the RP11 locus causing dominant retinitis pigmentosa is influenced by a gene linked to the homologous RP11 allele.

Authors:  T L McGee; M Devoto; J Ott; E L Berson; T P Dryja
Journal:  Am J Hum Genet       Date:  1997-11       Impact factor: 11.025

Review 2.  Genetic factors modifying clinical expression of autosomal dominant RP.

Authors:  Stephen P Daiger; Suma P Shankar; Alice B Schindler; Lori S Sullivan; Sara J Bowne; Terri M King; E Warick Daw; Edwin M Stone; John R Heckenlively
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

3.  Genome-wide linkage analysis to identify genetic modifiers of ALK mutation penetrance in familial neuroblastoma.

Authors:  Marcella Devoto; Claudia Specchia; Marci Laudenslager; Luca Longo; Hakon Hakonarson; John Maris; Yael Mossé
Journal:  Hum Hered       Date:  2011-07-06       Impact factor: 0.444

4.  Novel exon 2 α spectrin mutation and intragenic crossover: three morphological phenotypes associated with four distinct α spectrin defects.

Authors:  Sabina Swierczek; Archana M Agarwal; Kubendran Naidoo; Felipe R Lorenzo; Jonathan Whisenant; Roberto H Nussenzveig; Neeraj Agarwal; Theresa L Coetzer; Josef T Prchal
Journal:  Haematologica       Date:  2013-09-27       Impact factor: 9.941

5.  Structural and functional effects of hereditary hemolytic anemia-associated point mutations in the alpha spectrin tetramer site.

Authors:  Massimiliano Gaetani; Sara Mootien; Sandra Harper; Patrick G Gallagher; David W Speicher
Journal:  Blood       Date:  2008-01-24       Impact factor: 22.113

6.  Unravelling the genetic basis of variable clinical expression in neurofibromatosis 1.

Authors:  Audrey Sabbagh; Eric Pasmant; Ingrid Laurendeau; Béatrice Parfait; Sébastien Barbarot; Bernard Guillot; Patrick Combemale; Salah Ferkal; Michel Vidaud; Patrick Aubourg; Dominique Vidaud; Pierre Wolkenstein
Journal:  Hum Mol Genet       Date:  2009-05-05       Impact factor: 6.150

7.  Study on Management of Blood Transfusion Therapy in Patients with Hereditary Spherocytosis.

Authors:  Shiyue Ma; Lingjian Tang; Chaoli Wu; Hui Tang; Xue Pu; Jinhong Niu
Journal:  Appl Bionics Biomech       Date:  2022-01-28       Impact factor: 1.781

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.